-
Technology
-
Industry
-
Solutions
-
- ASSET MANAGEMENT
- AUGMENTED & VIRTUAL REALITY
- COLLABORATION
- CONVERSATIONAL
- CUSTOMER EXPERIENCE MANAGEMENT
- CUSTOMER RELATIONSHIP MANAGEMENT
- CYBER SECURITY
- DATA CENTER
- DIGITAL CUSTOMER EXPERIENCE
- DOCUMENT MANAGEMENT
- EHS SOFTWARE
- ELECTRONIC DATA INTERCHANGE
- ENTERPRISE DATA MANAGEMENT
- ENTERPRISE DATA QUALITY MONITORING
- ENTERPRISE RESOURCE PLANNING
- ENTERPRISE RISK MANAGEMENT
- ENTERPRISE-GRADE WEB DATA SOLUTIONS
- FACILITY MANAGEMENT
- FIELD SERVICE
- GAMIFICATION
- IDENTITY AND ACCESS MANAGEMENT
- INFRASTRUCTURE
- IT SERVICE MANAGEMENT
- MANAGED IT SERVICES
- PAYMENT AND CARD
- PROJECT MANAGEMENT
- SOFTWARE TESTING
- STORAGE
- VIDEO SOLUTIONS
- WORKFLOW
-
-
Platforms
-
Functions
- Leadership Perspectives
- Innovation Insights
- Research
- Magazines
- News
- CXO Awards
Amy Kao, Co-Founder & CMOTogether, the two Yale students created RxAll with the mission of "combatting counterfeit medicine in the emerging markets to ensure no one dies from fake drugs."
In line with this, RxAll has designed and built the world’s first medical authenticator that uses spectroscopy to verify authenticity of a drug in real-time. With its spectrometer, RxAll can scan the chemical compounds of a drug through radio frequency waves and compare it to the control database of authentic medicines to identify deviations in chemical composition. The data collected from the device is then fed to its cloud-based platform, which uses machine learning algorithms and AI intelligence to verify authenticity of the drug being scanned. The data is then sent back to the end customer through the RxAll app, informing them whether the drug is real or fake. At a local pharmacy, a consumer can scan a drug with the device before purchase and immediately perform real-time authentication.
RxAll’s primary customer base includes pharmaceutical companies, hospitals, and governments as well as larger companies who are eager to purchase the data from RxAll’s AI platform. These entities would be responsible for purchasing the RxAll spectrometers and distributing the devices to pharmacies within their network.
RxAll is an AI-hyperspectral platform for authenticating medicines and has built a proprietary molecular sensor device with a database of spectral signatures of medicines to carry out non-destructive pill authentication
At the pharmacy level, customers would only have to download the RxAll app (free of charge); the authentication service would be provided free of charge. “Through our B2B model, we want to ensure that we reach the most marginalized customers who would otherwise never be able to afford medicine authentication,” explains Kao.
RxAll is looking to expand its technology into other markets (food and cosmetics) in the coming years, but wants to focus on drug authentication in the short-term. RxAll’s biggest partner-- Ghana’s PharmAccess Foundation--is currently running a pilot across ten facilities in Ghana. RxAll also has a supply chain project with a university college hospital in Nigeria and a partnership with MERCK in Kenya; where it is working on a pharma co-vigilance surveillance project.
In terms of next steps: “We are looking at pharmaceutical companies and hospitals as our main partners. We also want to work with the government, regulatory agencies, policy makers, global organizations, and the general public because all stakeholders must be involved in fighting this problem.” says Kao with conviction. Her call to action is for stakeholders in developed nations to step up and become involved. “While we are a tackling a huge global health issue in the emerging markets, to defeat this battle against counterfeit medicines - success will be heavily dependent on an enlightened public and the support of the international community. We should all be in this fight together.”
Thanks to heroes like Kao and Alonge, the world is getting one step closer to eliminating counterfeit medicine.
Octamile Partners RxAll to Expand Access to Health Insurance
Thursday, August 10, 2023
Insuretech company, Octamile has partnered with RxAll, a key player in health technology to to make quality healthcare accessible to everyone, starting in Africa, by offering affordable and comprehensive health insurance packages through a seamless platform, they aim.
RxAll is a health-tech platform that aims to improve access to affordable healthcare services and high-quality medicines worldwide, focusing on Africa. To achieve this goal, RxAll has developed advanced technological solutions such as a drug testing platform, pharmacy management software, an invoice financing platform, and retail outlets known as the RxGO Pharmacy Network.
Octamile has collaborated with RxAll to develop a dedicated portal for the sale and purchase of health insurance. This portal empowers RxAll agents to efficiently distribute health insurance to their customers, whether families or individuals. The seamless integration of Octamile’s expertise and technology within the RxAll platform ensures a streamlined and user-friendly experience for customers seeking comprehensive health insurance coverage.
The cost-effectiveness of the available health insurance plans is one of the partnership’s main advantages. A wide range of healthcare services, including general and specialised consultations, accident and emergency care, ambulance services, basic diagnostic imaging, laboratory tests, hospitalisation, intensive care, dental care, immunisations, and even surgeries, are available to individuals and families for as little as N 1,600.
The comprehensive coverage provided by these health insurance packages ensures peace of mind for customers, safeguarding them from unexpected healthcare expenses.
Adebayo Alonge, the CEO of RxAll, Inc., said, “We were looking to include insurance products on our platform so that our merchants and consumers could easily access insurance to protect their businesses, health and assets. The Octamile platform was by far the easiest to integrate, and we are excited to get our customers across Nigeria to easily buy any type of insurance they need on our platform in person or digitally. We look forward to expanding this offering with Octamile into our other countries of operations in the rest of Africa”
By joining forces, Octamile and RxAll are addressing the pressing need for accessible and affordable healthcare solutions. This partnership not only enables RxAll agents to expand their services by offering health insurance options to their customers but also empowers individuals and families to manage their healthcare needs proactively. Through the user-friendly portal developed by Octamile, customers can easily explore and purchase health insurance packages that align with their specific needs.
Gbenro Dara, the CEO of Octamile, expressed enthusiasm about the collaboration, stating, “This partnership between Octamile and RxAll marks a significant milestone in the healthcare industry. By leveraging Octamile’s expertise in insurtech and RxAll’s commitment to healthcare innovation, individuals and families can now enjoy the benefits of affordable health insurance coverage.”
RxAll, Inc. Joins CGI Greenhouse 2024 Cohort, Launches Key Initiatives to Transform African Healthcare
Thursday, September 26, 2024
RxAll, Inc., the digital operating system for African pharmacies, is proud to announce its selection for the prestigious CGI Greenhouse 2024 cohort. This global recognition underscores RxAll’s commitment to enhancing healthcare delivery across Africa by empowering pharmacies to unlock the value of their transaction data.
With over 1 billion Africans relying on neighborhood pharmacies for essential healthcare services, many of these vital outlets face significant challenges. They struggle to effectively utilize their transaction data, leading to issues such as the prevalence of low-quality and expired medicines, frequent stockouts, and unnecessarily high prices. RxAll is dedicated to addressing these problems by providing innovative digital solutions that help pharmacies better serve their communities.
Currently, RxAll partners with over 5,000 pharmacies across Africa, reaching approximately 3 million patients each month. Through its cutting-edge platform, RxAll is transforming the way these pharmacies operate, enabling them to improve medication quality, reduce stockouts, and offer more competitive pricing.
As part of its participation in the CGI Greenhouse 2024 cohort, RxAll is excited to announce its Commitment to Action, which includes several key initiatives aimed at revolutionizing healthcare in Africa:
1. AI for Disease Mapping: Leveraging artificial intelligence to enhance disease detection and response across the continent, enabling faster and more accurate healthcare interventions.
2. Documentary on Fake Drugs: Raising awareness about the dangers of counterfeit medicines, a critical issue that threatens the health and safety of millions of Africans.
3. Private Label Antibiotics: Introducing high-quality antibiotics in partnership with credible local African pharmaceutical manufacturers. This initiative aims to reassure patients of their medication’s safety, particularly in this crucial therapeutic category.
“We are thrilled to be part of the CGI Greenhouse 2024 cohort, which provides us with a unique platform to further our mission of improving healthcare delivery across Africa,” said Adebayo Alonge, CEO of RxAll. “These new initiatives are a testament to our commitment to empowering African pharmacies with the tools and technology they need to provide better healthcare outcomes for their patients.”
The announcement marks a significant milestone for RxAll as it continues to lead the digital transformation of the African healthcare sector. The company’s innovative approach has already garnered attention and support from key stakeholders across the industry, and these new projects are expected to further solidify its impact.
Company
RxAll
Management
Amy Kao, Co-Founder & CMO
Description
Uses a mobile spectrometer with a cloud-based AI algorithms and database of spectral signatures of medicines to carry out non-destructive pill authentication
